Skip to content

To clarify the relation between NHO voice therapy and Substance P (Exploring the Relation between Glottal Closure and Plasma Substance P)

To clarify the relation between NHO voice therapy and Substance P (Exploring the Relation between Glottal Closure and Plasma Substance P) - NHO voice therapy(Vocal / swallowing disorder training) and Substance P

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000035080
Enrollment
180
Registered
2018-12-13
Start date
2018-12-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glottal incompetence, vocal fold atrophy aged

Interventions

None listed

Sponsors

National Hospital Organization Tokyo Medical Center (Clinical Research Center)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. equal and more than 65years old 2.Patient complained breathy hoarseness, cough or dysphagia. 3.Agree with NHO voice therapy 4.understood the clinical research 5.Patients has no Neuropsychi-atric disorders 6.No inflammation, tum-or paralysis, polyp, glanuloma etc. on patients vocal fold. 7.vocal fold atrohy in both side and recognized glottal incompetence 8.possible to visit hospital. 9. responsible physician in each hospital agreed with the indication of voice therapy.

Exclusion criteria

Exclusion criteria: 1. Patient could not understand Japanese or could not record training diary. 2. Patient cloud not perform voice therapy. 3. Value of the maximum phonation time was equal and more than 15 seconds.

Design outcomes

Primary

MeasureTime frame
Maximum phonation time (MPT),Comparison with Substance P before the voice therapy and after 6-months voice therapy.

Countries

Japan

Contacts

Public ContactKoichi Tsunoda, MD.PhD

National Hospital Organization Clinical Research Center Sensory Center Artificial organ / device development research department

koichi.tsunoda@kankakuki.jp+81-3-3411-0111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026